고젖산혈증 또는 중증 장기부전이 없는 패혈성 쇼크 환자의 예후 분석
Favorable Outcomes in Septic Shock Patients without Hyperlactatemia or Severe Organ Failure
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background: Septic shock is a pathophysiologic state of circulatory failure with tissue hypoperfusion. However, it is usually defined as sepsis-induced hypotension not responding to fluid resuscitation, regardless of the objective findings of tissue hypoperfusion such as lactic acidosis or organ failures. Numerous patients with sepsis-induced hypotension present to the emergency department without hyperlactemia or severe organ failure. Hence, we investigated the clinical characteristics and outcomes of patients with septic shock according to the presence of hyperlactatemia or significant organ failure. Methods: We conducted a retrospective observational study of adult patients presenting with septic shock in the emergency department of a tertiary care hospital between August 2008 and July 2010. Initial serum lactate was categorized low (＜2.5 mmol/L) and high (≥2.5 mmol/L). Organ failure was assessed by the Sequential Organ Failure Assessment (SOFA) score. Primary outcome measurement was in-hospital mortality. Results: A total of 227 patients were enrolled. There were 88 (38.8%) patients in the low lactate group, and 139 (61.2%) patients in the high lactate group. Patients with low lactate levels showed a lower mortality rate (6.8% compared with 25.1% of those with high lactate level). The low lactate group showed less rapid heart rate, less severe organ failures and shorter length of stay in the intensive care unit. During the early goal-directed therapy, they required a smaller amount of fluid administration and a lower dose of norepinephrine although other hemodynamic variables were similarly maintained. In particular, if patients showed less severe organ dysfunction (SOFA score ＜ 8) in the low lactate group (n = 45), in-hospital mortality was 0% (adjusted mortality was 1.3% [95% confidence interval = 0.3－5.0]). Conclusion: Patients with septic shock, who were enrolled according to the traditional definition, showed a very favorable outcome if they did not have hyperlactatemia or significant organ failure.
Abstract
Background: Septic shock is a pathophysiologic state of circulatory failure with tissue hypoperfusion. However, it is usually defined as sepsis-induced hypotension not responding to fluid resuscitation, regardless of the objective findings of tissue hypoperfusion such as lactic acidosis or organ failures. Numerous patients with sepsis-induced hypotension present to the emergency department without hyperlactemia or severe organ failure. Hence, we investigated the clinical characteristics and outcomes of patients with septic shock according to the presence of hyperlactatemia or significant organ failure. Methods: We conducted a retrospective observational study of adult patients presenting with septic shock in the emergency department of a tertiary care hospital between August 2008 and July 2010. Initial serum lactate was categorized low (＜2.5 mmol/L) and high (≥2.5 mmol/L). Organ failure was assessed by the Sequential Organ Failure Assessment (SOFA) score. Primary outcome measurement was in-hospital mortality. Results: A total of 227 patients were enrolled. There were 88 (38.8%) patients in the low lactate group, and 139 (61.2%) patients in the high lactate group. Patients with low lactate levels showed a lower mortality rate (6.8% compared with 25.1% of those with high lactate level). The low lactate group showed less rapid heart rate, less severe organ failures and shorter length of stay in the intensive care unit. During the early goal-directed therapy, they required a smaller amount of fluid administration and a lower dose of norepinephrine although other hemodynamic variables were similarly maintained. In particular, if patients showed less severe organ dysfunction (SOFA score ＜ 8) in the low lactate group (n = 45), in-hospital mortality was 0% (adjusted mortality was 1.3% [95% confidence interval = 0.3－5.0]). Conclusion: Patients with septic shock, who were enrolled according to the traditional definition, showed a very favorable outcome if they did not have hyperlactatemia or significant organ failure.
참고문헌 (23)
- Angus DC, "Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care", Crit Care Med, 29, pp.1303~1310 (2001)
- Bone RC, "Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP", SCCM Consensus Conference Committee. American College of Chest Physicians, Chest, pp.1992, 101[DOI]
- Levy MM, "2001 SCCM", ESICM, ATS, pp.SIS International Sepsis Definitions Conference, Crit Care Med[DOI]
- Hernandez G, "Persistent sepsis-induced hypotension without hyperlactatemia: is it really septic shock?", J Crit Care, 26, pp.435~ (2011)
- Nguyen HB, "Early lactate clearance is associated with improved outcome in severe sepsis and septic shock", Crit Care Med, 32, pp.1637~1642 (2004)
- Jones AE, "Investigators: Lactate clearance vs central venous oxygen saturation as goals of early sepsis therapy: a randomized clinical trial", JAMA, 303, pp.739~746 (2010)
- Jones AE, "The Sequential Organ Failure Assessment score for predicting outcome in patients with severe sepsis and evidence of hypoperfusion at the time of emergency department presentation", Crit Care Med, 37, pp.1649~1654 (2009)
- Shapiro NI, "Serum lactate as a predictor of mortality in emergency department patients with infection", Ann Emerg Med, 45, pp.524~528 (2005)
- Mikkelsen ME, "Serum lactate is associated with mortality in severe sepsis independent of organ failure and shock", Crit Care Med, 37, pp.1670~1677 (2009)
- Bone RC, "The ACCP", SCCM Consensus Conference Committee. American College of Chest Physicians, Chest, pp.2009, 136(5 Suppl)[DOI]
- Rivers E, "Early goal-directed therapy in the treatment of severe sepsis and septic shock", N Engl J Med, 345, pp.1368~1377 (2001)
- Dellinger RP, "Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008", Crit Care Med, 36, pp.296~327 (2008)
- Jeon K, "Improvements in compliance with resuscitation bundles and achievement of end points after an educational program on the management of severe sepsis and septic shock", Shock, 37, pp.463~467 (2012)
- Mikkelsen ME, "Factors associated with nonadherence to early goal-directed therapy in the ED", Chest, 138, pp.551~558 (2010)
- Jones AE, "The Sequential Organ Failure Assessment score for predicting outcome in patients with severe sepsis and evidence of hypoperfusion at the time of emergency department presentation", Crit Care Med, 37, pp.1649~1654 (2009)
- Vincent JL, "The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction", failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine, 1996, pp.22, 707~710
- Hotchkiss RS, "The pathophysiology and treatment of sepsis", N Engl J Med, 348, pp.138~150 (2003)
- Okazaki Y, "Pathophysiology of sepsis and recent patents on the diagnosis, treatment and prophylaxis for sepsis", Recent Pat Inflamm Allergy Drug Discov, 3, pp.26~32 (2009)
- Jansen TC, "Early lactate- guided therapy in intensive care unit patients: a multicenter, open-label, randomized controlled trial", Am J Respir Crit Care Med, 182, pp.752~761 (2010)
- 이성우, "Lactic acidosis not hyperlactatemia as a predictor of inhospital mortality in septic emergency patients", EMERG MED J, 25, pp.659~665 (2008)
- Peres Bota D, "The Multiple Organ Dysfunction Score (MODS) versus the Sequential Organ Failure Assessment (SOFA) score in outcome prediction", Intensive Care Med, 28, pp.1619~1624 (2002)
- Trzeciak S, "Serum lactate as a predictor of mortality in patients with infection", Intensive Care Med, 33, pp.970~977 (2007)
- Nguyen HB, "Severe sepsis and septic shock: review of the literature and emergency department management guidelines", Ann Emerg Med, 48, pp.28~54 (2006)